- Idexx Laboratories shares rose 21.8%.
- The company reported better-than-expected earnings.
Idexx Laboratories shares surged 21.8% after the company beat earnings expectations and raised its full-year EPS guidance to $14.96-$15.16. The stock broke through its 200-day moving average. The broader market was mixed, with the Dow up 0.4% and the Nasdaq down 1.1%.
One free account opens every story complete, the live board, the 30-day calendar, a watchlist and breaking alerts on your phone. No card. The wire stays free to read.